Recombinant Human CLDN20 Protein，GST

CLDN20, or Claudin 20, is a member of the claudin family of proteins that play a crucial role in the formation and maintenance of tight junctions between epithelial cells. These junctions are essential for creating selective barriers that regulate the passage of ions, solutes, and water between tissues. While most claudins have been well-studied, the specific functions and mechanisms of CLDN20 remain less understood. Research has indicated that CLDN20 may be involved in various physiological processes, including renal function and the integrity of the blood-brain barrier, suggesting its potential relevance in both health and disease. Dysregulation of claudin expression has been linked to several pathological conditions, including cancer and kidney diseases, highlighting the importance of elucidating its role at the molecular level. The study of CLDN20 recombinant proteins aims to investigate its structural properties, binding interactions, and functional capabilities within cell models. Understanding the role of CLDN20 could provide insights into its involvement in tight junction dynamics and its potential as a therapeutic target or biomarker for relevant diseases. As research continues, the development of CLDN20 recombinant proteins offers a promising approach to advance our knowledge of this protein’s biological significance and its implications in various cellular processes.